Fmoc-Tyr(Boc-Nmec)-OH |
| Catalog No.GA21823 |
Fmoc-Tyr derivative for improving the solubility of hydrophobic peptides after cleavage from the resin, as removal of Boc leaves a charged moiety. After purification, the solubilizing Nmec (N-methyl-N-[2-(methylamino)ethyl]carbamoyl) group is split off via an intramolecular cyclization in neutral or slightly basic solution.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1033814-21-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Fmoc-Tyr derivative for improving the solubility of hydrophobic peptides after cleavage from the resin, as removal of Boc leaves a charged moiety. After purification, the solubilizing Nmec (N-methyl-N-[2-(methylamino)ethyl]carbamoyl) group is split off
Average Rating: 5 (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *